| NCT ID | NCT05322343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Brain |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,050 participants |
| Start Date | 2022-03-22 |
| Primary Completion | 2030-03-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,050 participants in total. It began in 2022-03-22 with a primary completion date of 2030-03-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general population from the age of 55 (the approximate age of onset of the first cognitive disorders and a target population particularly receptive to prevention messages). Special interest will be given to nutrition, a promising environmental exposure for prevention.
Eligibility Criteria
Inclusion Criteria: For the main study: 1. live in Bordeaux metropolitan area, 2. be between 55 and 80 years old (included), 3. selected in terms of socioeconomic level, according to a sampling strategy by age groups and income categories representative of the general population between 55 and 80 years of age 4. be affiliated with the social security system, 5. agree to take a blood sample for the biobank. For the MRI sub-study: be between 55 and 75 years old (included). Inclusion criteria for the immune response substudy: be 70 years of age or older or participate in the MRI study; agree to take a supplemental blood sample for this substudy. Exclusion Criteria: For the main study: persons under guardianship (or more generally under protection), unable to give consent to participate. For the MRI sub-study: have a contraindication to MRI examination (pacemaker, a valve prosthesis or any other internal electrical/magnetic device; history of neurosurgery or aneurysm; claustrophobia; presence of metal fragments in the eyes, brain or spinal cord).
Contact & Investigator
Cécilia SAMIERI, Dr
PRINCIPAL INVESTIGATOR
Bordeaux Population Health Researh Center Inserm
Frequently Asked Questions
Who can join the NCT05322343 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 80 Years, studying Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05322343 currently recruiting?
Yes, NCT05322343 is actively recruiting participants. Contact the research team at cecilia.samieri@u-bordeaux.fr for enrollment information.
Where is the NCT05322343 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT05322343 clinical trial?
NCT05322343 is sponsored by University Hospital, Bordeaux. The principal investigator is Cécilia SAMIERI, Dr at Bordeaux Population Health Researh Center Inserm. The trial plans to enroll 2,050 participants.